These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16702374)

  • 1. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
    Sutcliffe S; Giovannucci E; Alderete JF; Chang TH; Gaydos CA; Zenilman JM; De Marzo AM; Willett WC; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):939-45. PubMed ID: 16702374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.
    Stark JR; Judson G; Alderete JF; Mundodi V; Kucknoor AS; Giovannucci EL; Platz EA; Sutcliffe S; Fall K; Kurth T; Ma J; Stampfer MJ; Mucci LA
    J Natl Cancer Inst; 2009 Oct; 101(20):1406-11. PubMed ID: 19741211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.
    Sutcliffe S; Alderete JF; Till C; Goodman PJ; Hsing AW; Zenilman JM; De Marzo AM; Platz EA
    Int J Cancer; 2009 May; 124(9):2082-7. PubMed ID: 19117055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
    Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer.
    Sutcliffe S; Giovannucci E; De Marzo AM; Leitzmann MF; Willett WC; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2160-6. PubMed ID: 17119041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study.
    Saleh NE; Alhusseiny SM; El-Zayady WM; Aboelnaga EM; El-Beshbishi WN; Saleh YM; Abou-ElWafa HS; El-Beshbishi SN
    Parasitol Res; 2021 Apr; 120(4):1379-1388. PubMed ID: 33159459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
    Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
    Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.
    Korodi Z; Dillner J; Jellum E; Lumme S; Hallmans G; Thoresen S; Hakulinen T; Stattin P; Luostarinen T; Lehtinen M; Hakama M
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2952-5. PubMed ID: 16365015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.
    Patel DA; Bock CH; Schwartz K; Wenzlaff AS; Demers RY; Severson RK
    Cancer Causes Control; 2005 Apr; 16(3):263-73. PubMed ID: 15947878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms.
    Sutcliffe S; Giovannucci E; De Marzo AM; Willett WC; Platz EA
    Am J Epidemiol; 2005 Nov; 162(9):898-906. PubMed ID: 16177142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.
    Kurahashi N; Iwasaki M; Inoue M; Sasazuki S; Tsugane S
    J Clin Oncol; 2008 Dec; 26(36):5923-9. PubMed ID: 19018085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An iatrogenic confounding variable.
    Albertsen PC
    J Natl Cancer Inst; 2009 Oct; 101(20):1368-9. PubMed ID: 19741210
    [No Abstract]   [Full Text] [Related]  

  • 13. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.
    Van Der Pol B; Kwok C; Pierre-Louis B; Rinaldi A; Salata RA; Chen PL; van de Wijgert J; Mmiro F; Mugerwa R; Chipato T; Morrison CS
    J Infect Dis; 2008 Feb; 197(4):548-54. PubMed ID: 18275275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichomoniasis in men: old issues and new data.
    Krieger JN
    Sex Transm Dis; 1995; 22(2):83-96. PubMed ID: 7624817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.
    Sarma AV; McLaughlin JC; Wallner LP; Dunn RL; Cooney KA; Schottenfeld D; Montie JE; Wei JT
    J Urol; 2006 Sep; 176(3):1108-13. PubMed ID: 16890703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer and sexually transmitted diseases: a meta-analysis.
    Taylor ML; Mainous AG; Wells BJ
    Fam Med; 2005; 37(7):506-12. PubMed ID: 15988645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: a case-control study in Cuba.
    Fernández L; Galán Y; Jiménez R; Gutiérrez A; Guerra M; Pereda C; Alonso C; Riboli E; Agudo A; González C
    Int J Epidemiol; 2005 Feb; 34(1):193-7. PubMed ID: 15375086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
    Sutcliffe S; Giovannucci E; Gaydos CA; Viscidi RP; Jenkins FJ; Zenilman JM; Jacobson LP; De Marzo AM; Willett WC; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1573-80. PubMed ID: 17684131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.